NCT05982522 2026-03-27IN10018 Combination Therapy in Previously-treated Solid TumorsInxMed (Shanghai) Co., Ltd.Phase 1/2 Withdrawn
NCT06487858 2026-03-18A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid TumorsBeOne MedicinesPhase 1 Active not recruiting75 enrolled